Use of protamine sulfate during transfemoral transcatheter aortic valve implantation – a preliminary assessment of administration rate and impact on complications
Guardado en:
Autores principales: | Karol Zbroński, Kajetan Grodecki, Roksana Gozdowska, Szymon Jędrzejczyk, Ewa Ostrowska, Julia Wysińska, Bartosz Rymuza, Piotr Scisło, Radosław Wilimski, Janusz Kochman, Krzysztof J. Filipiak, Grzegorz Opolski, Zenon Huczek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1cf4c201337545a4872ca36552c4aab2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery
por: Yu X, et al.
Publicado: (2016) -
Heart Team for Optimal Management of Patients with Severe Aortic Stenosis—Long-Term Outcomes and Quality of Life from Tertiary Cardiovascular Care Center
por: Szymon Jonik, et al.
Publicado: (2021) -
Interventional Treatment of Access Site Complications During Transfemoral TAVI: A Single Center Experience
por: Marcus Thieme, et al.
Publicado: (2021) -
Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome
por: Park CK, et al.
Publicado: (2017) -
Enhanced Efficacy of Photodynamic Therapy by Coupling a Cell-Penetrating Peptide with Methylene Blue
por: Ser J, et al.
Publicado: (2020)